KEAP1 mutations have been associated with reduced survival in lung adenocarcinoma (LUAD) patients treated with immune checkpoint inhibitors (ICIs), particularly in the presence of STK11/KRAS alterations. We hypothesized that, beyond co-occurring genomic events, clonality prediction may help identify deleterious KEAP1 mutations and their counterparts with retained sensitivity to ICIs.
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma / Scalera, S; Ricciuti, B; Mazzotta, M; Calonaci, N; Alessi, Joao V; Cipriani, L; Bon, G; Messina, B; Lamberti, G; Di Federico, A; Pecci, F; Milite, S; Krasniqi, E; Barba, M; Vici, P; Vecchione, A; De Nicola, F; Ciuffreda, L; Goeman, F; Fanciulli, M; Buglioni, S; Pescarmona, E; Sharma, B; Felt, K D; Lindsay, J; Rodig, S J; De Maria, R; Caravagna, G; Cappuzzo, F; Ciliberto, G; Awad, M M; Maugeri-Saccà, M. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - (2022), pp. 1-35. [10.1016/j.annonc.2022.12.002]
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
Mazzotta, M;Bon, G;Di Federico, A;Pecci, F;Vecchione, A;Ciuffreda, L;Goeman, F;Pescarmona, E;
2022
Abstract
KEAP1 mutations have been associated with reduced survival in lung adenocarcinoma (LUAD) patients treated with immune checkpoint inhibitors (ICIs), particularly in the presence of STK11/KRAS alterations. We hypothesized that, beyond co-occurring genomic events, clonality prediction may help identify deleterious KEAP1 mutations and their counterparts with retained sensitivity to ICIs.| File | Dimensione | Formato | |
|---|---|---|---|
|
Scalera_Clonal-KEAP1_2022.pdf
solo gestori archivio
Note: articolo in rivista
Tipologia:
Documento in Pre-print (manoscritto inviato all'editore, precedente alla peer review)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
6.02 MB
Formato
Adobe PDF
|
6.02 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
